Kratos Pharmaceuticals Limited - Company Profile

It is a chemicals public limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Kratos Pharmaceuticals Limited

Kratos Pharmaceuticals Limited, a struck off public limited company, was established on 16 May 2011 in Mumbai, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2011PLC217498. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Irfan Ahmed Khan (Director), Nikhil Ratilal Shah (Director), Rajesh Raghunath Pawar (Director). Past directors included Darayus Kersasp Paowalla, Rajesh Raghunath Pawar. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at 317, Maker Chambers V 221, Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2011PLC217498

  • Registration Number

    217498

  • Incorporation Date

    16 May 2011

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Kratos Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kratos Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kratos Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Irfan Ahmed Khan Director 16 May 2011 Current
Nikhil Ratilal Shah Director 16 May 2011 Current
Rajesh Raghunath Pawar Director 25 Apr 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Apr 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kratos Pharmaceuticals.

Enhance accessibility to Kratos Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kratos Pharmaceuticals revenue growth over time
Kratos Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kratos Pharmaceuticals?

Unlock access to Kratos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kratos Pharmaceuticals?

Unlock and access historical data on people associated with Kratos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kratos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kratos Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kratos Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Kratos Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was completed.

  • Director Appointment

    The activity Rajesh Raghunath Pawar was appointed as a Director was appointed as a Director on 25 Apr 2013 & has been associated with this company since 12 years 9 months . was completed.

  • Balance Sheet

    Kratos Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Irfan Ahmed Khan was appointed as a Director was appointed as a Director on 16 May 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Nikhil Ratilal Shah was appointed as a Director was appointed as a Director on 16 May 2011 & has been associated with this company since 14 years 8 months . was completed.

  • Company Incorporation

    The activity Kratos Pharmaceuticals Limited was registered on 16 May 2011 with Roc Mumbai & aged 14 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kratos Pharmaceuticals Limited?

The CIN of Kratos Pharmaceuticals Limited is U24100MH2011PLC217498.

Where is Kratos Pharmaceuticals Limited headquartered?

Kratos Pharmaceuticals Limited is headquartered at 317, Maker Chambers V 221, Nariman Point, Mumbai, Maharashtra, 400021.

When was Kratos Pharmaceuticals Limited incorporated?

Kratos Pharmaceuticals Limited was incorporated on 16 May 2011.

Who are the current directors of Kratos Pharmaceuticals Limited?

The current directors of Kratos Pharmaceuticals Limited are

What is the primary industry of Kratos Pharmaceuticals Limited?

The primary industry of Kratos Pharmaceuticals Limited is Chemicals.

Is Kratos Pharmaceuticals Limited a listed company?

Kratos Pharmaceuticals Limited is unlisted.

What is the capital structure of Kratos Pharmaceuticals Limited?

The authorized capital of Kratos Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available